Bayer Aktie: UBS und Goldman wollen jetzt 66 Euro sehen
Bayer steigerte Umsatz und EBITDA im dritten Quartal 2026 und verbesserte den Jahresausblick; zudem erhielt Sevabertinib die Zulassung in China.
The report was published on 07 de novembro de 2026 às 13:00 by Finanztrends and is part of the World news coverage.
Quick answers
Who reported this story?
It was first reported by Finanztrends on 07 de novembro de 2026 às 13:00.
What is the category?
It is filed under World news on Rio Warzone News.
